πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 29,054 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11878053

Vaccine compositions comprising tryptophan 2,3-dioxygenase or fragments thereof

IO Biotech ApS Β· Granted Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11878002

Methods and materials for using Ruminococcus gnavus or Clostridium sporogenes to treat gas

The Regents of the University of California Β· Granted Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11878064

Nanoparticle/peptide method of blocking potassium channels

The Government of the United States of America, as represented by the Secretary of the Navy Β· Granted Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11877989

Nutritional supplement containing L-Ξ±-glycerophosphorylcholine

Energy Beverages LLC Β· Granted Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11878964

Compositions comprising an urolithin compound

Amazentis SA Β· Granted Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11879003

Methods for increasing T-cell function

Kyverna Therapeutics, Inc. Β· Granted Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11878977

JAK inhibitors containing a 4-membered heterocyclic amide

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11873495

Compounds and methods for reducing LRRK2 expression

Ionis Pharmaceuticals, Inc. Β· Granted Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11873300

Crystalline forms of CFTR modulators

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11873319

Cyclic di-nucleotide induction of type I interferon

The Regents of the University of California Β· Granted Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11873296

Solid forms of a dual RAF/MEK inhibitor

VERASTEM, INC. Β· Granted Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11873350

Dissolution of oxidized cellulose

Covidien LP Β· Granted Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11873490

Antisense oligomers for treatment of conditions and diseases

STOKE THERAPEUTICS, INC. Β· Granted Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11872200

GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA co

The Regents of the University of California Β· Granted Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11872203

Methods of administering solriamfetol to lactating women

AXSOME MALTA LTD. Β· Granted Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11872204

Methods of administering solriamfetol to lactating women

AXSOME MALTA LTD. Β· Granted Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11872261

Lipoprotein targeting protease inhibitors and uses

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11873288

Inhibitors for soluble epoxide hydrolase (sEH) and fatty acid amide hydrolase (FAAH)

The Regents of the University of California Β· Granted Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11872225

Pyruvate kinase modulators and use thereof

Agios Pharmaceuticals, Inc. Β· Granted Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11873291

Quinoline cGAS antagonist compounds

The Board of Regents of the University of Texas System Β· Granted Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11872092

Methods for surgical guidance in breast cancer surgery and lymph node dissection using two

The Board of Regents of the University of Texas System Β· Granted Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11872355

Medical device for detecting fluid parameters using fluorescent probes

Covidien LP Β· Granted Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11872312

Neuroprotective liposome compositions and methods for treatment of stroke

The Board of Regents of the University of Texas System Β· Granted Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11872244

Thixotropic oxidized cellulose solutions and medical applications thereof

Covidien LP Β· Granted Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted